Yes that is correct lex.. now Fraser's team will analyse this data (they are the experts after all) and make decisions on how/if to continue. What we had was a PowerPoint slide show that was produced over night for presentation. (If Wayne's comments are correct about the timing of receiving results). I feel the HPV trials will be arranged very differently from what they now know.
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-91
-
- There are more pages in this discussion • 260 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.31 |
Change
-0.600(6.05%) |
Mkt cap ! $196.8M | |||
| Open | High | Low | Value | Volume |
| $9.50 | $9.77 | $9.30 | $136.9K | 14.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 915 | $9.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.53 | 1516 | 4 |
View Market Depth
| Last trade - 15.42pm 13/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |